Norges Bank’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,704,265
Closed -$1.26B 614
2025
Q4
$1.26B Buy
+2,704,265
New +$1.26B 0.14% 124
2025
Q3
Sell
-3,008,113
Closed -$1.15B 684
2025
Q2
$1.15B Buy
3,008,113
+72,889
+2% +$26.3M 0.14% 134
2025
Q1
$1.01B Buy
2,935,224
+135,671
+5% +$43.6M 0.14% 133
2024
Q4
$840M Sell
2,799,553
-81,393
-3% -$28.4M 0.11% 164
2024
Q3
$1.17B Buy
2,880,946
+11,465
+0.4% +$4.2M 0.16% 121
2024
Q2
$922M Buy
2,869,481
+302,445
+12% +$98.3M 0.14% 141
2024
Q1
$856M Sell
2,567,036
-516
-0% -$158K 0.14% 147
2023
Q4
$695M Buy
2,567,552
+161,165
+7% +$39.8M 0.12% 166
2023
Q3
$592M Sell
2,406,387
-97,473
-4% -$26.7M 0.12% 171
2023
Q2
$760M Buy
2,503,860
+129,647
+5% +$36M 0.15% 131
2023
Q1
$626M Buy
2,374,213
+94,235
+4% +$23.9M 0.14% 148
2022
Q4
$547M Buy
2,279,978
+241,588
+12% +$54.1M 0.13% 162
2022
Q3
$375M Sell
2,038,390
-13,702
-0.7% -$2.73M 0.1% 200
2022
Q2
$345M Sell
2,052,092
-201,421
-9% -$43.3M 0.09% 217
2022
Q1
$565M Sell
2,253,513
-67,816
-3% -$17M 0.12% 162
2021
Q4
$596M Sell
2,321,329
-103,546
-4% -$25.3M 0.12% 155
2021
Q3
$589M Sell
2,424,875
-294,370
-11% -$72M 0.13% 151
2021
Q2
$562M Sell
2,719,245
-153,432
-5% -$31.3M 0.12% 165
2021
Q1
$541M Sell
2,872,677
-460,349
-14% -$81.2M 0.12% 165
2020
Q4
$548M Buy
3,333,026
+388,519
+13% +$56.8M 0.13% 159
2020
Q3
$367M Sell
2,944,507
-47,561
-2% -$5.89M 0.1% 183
2020
Q2
$290M Buy
2,992,068
+33,213
+1% +$3.45M 0.08% 220
2020
Q1
$266M Buy
2,958,855
+9,388
+0.3% +$1.22M 0.09% 196
2019
Q4
$436M Hold
2,949,467
0.12% 172
2019
Q3
$355M Hold
2,949,467
0.11% 187
2019
Q2
$399M Buy
2,949,467
+37,931
+1% +$4.8M 0.12% 165
2019
Q1
$380M Buy
2,911,536
+23,701
+0.8% +$3.18M 0.12% 162
2018
Q4
$359M Buy
2,887,835
+3,600
+0.1% +$483K 0.13% 147
2018
Q3
$401M Hold
2,884,235
0.13% 150
2018
Q2
$296M Hold
2,884,235
0.1% 201
2018
Q1
$280M Sell
2,884,235
-347,721
-11% -$33.7M 0.1% 198
2017
Q4
$284M Hold
3,231,956
0.1% 200
2017
Q3
$257M Hold
3,231,956
0.1% 206
2017
Q2
$282M Buy
3,231,956
+5,804
+0.2% +$491K 0.11% 190
2017
Q1
$287M Buy
3,226,152
+59,826
+2% +$4.99M 0.12% 175
2016
Q4
$234M Hold
3,166,326
0.1% 199
2016
Q3
$229M Sell
3,166,326
-53,091
-2% -$4.07M 0.11% 189
2016
Q2
$248M Sell
3,219,417
-200,325
-6% -$15.8M 0.12% 173
2016
Q1
$267M Buy
3,419,742
+430,438
+14% +$30.1M 0.13% 149
2015
Q4
$202M Buy
2,989,304
+723,211
+32% +$50.4M 0.1% 194
2015
Q3
$175M Sell
2,266,093
-119,599
-5% -$10.6M 0.09% 208
2015
Q2
$216M Buy
2,385,692
+71,890
+3% +$5.76M 0.11% 186
2015
Q1
$174M Buy
2,313,802
+298,524
+15% +$21.4M 0.09% 234
2014
Q4
$148M Sell
2,015,278
-87,938
-4% -$6.18M 0.08% 256
2014
Q3
$148M Sell
2,103,216
-2,165,616
-51% -$143M 0.08% 234
2014
Q2
$241M Buy
4,268,832
+2,134,416
+100% +$113M 0.06% 280
2014
Q1
$112M Hold
2,134,416
0.06% 294
2013
Q4
$102M Sell
2,134,416
-558,898
-21% -$25.8M 0.06% 310
2013
Q3
$115M Sell
2,693,314
-47,203
-2% -$1.84M 0.07% 294
2013
Q2
$98.8M Buy
+2,740,517
New +$106M 0.06% 306

Other funds holding HCA

Norges Bank's HCA Position: Q1 2026 in Review

Norges Bank sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 2,704,265 shares — an estimated $1.26B sold.

Norges Bank first reported a position in HCA in Q2 2013 and held it in 50 quarters. The position peaked at $1.26B in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Norges Bank reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 2,704,265 HCA Healthcare shares in Q1 2026, an estimated $1.26B.
  • Norges Bank first reported a position in HCA Healthcare in Q2 2013 and held it in 50 quarters.
  • Norges Bank's HCA Healthcare position peaked at $1.26B in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.